Results 141 to 150 of about 17,488 (290)
A considerable number of oral antitumor therapeutics (OAT) has the potential for causing pseudo‐worsening of kidney function (PW) due to inhibition of renal creatinine secretion, i.e., kidney function is unaffected, while creatinine‐based calculation of glomerular filtration rate (eGFR) erroneously indicates an impaired kidney function.
Michael I. Sponfeldner +13 more
wiley +1 more source
The aim of this investigation was to identify by in silico and in vitro methods the physico-chemical properties impact on bioavailability of three fluoroquinolones second, third and fourth generation in relation to Biopharmaceutics Classification System.
Ewa Kłosińska-Szmurło +5 more
doaj
Baloxavir acid (baloxavir), the active metabolite of the prodrug baloxavir marboxil, is a selective inhibitor of the influenza virus cap‐dependent endonuclease. The population pharmacokinetic (popPK) profile of baloxavir in adults/adolescents has been described previously.
Sylvie Retout +6 more
wiley +1 more source
Maternal health remains a critical global concern, particularly in underserved populations and in low‐ and middle‐income countries where access to safe and effective therapeutics is limited. Despite the use of medications by most women during pregnancy, the exclusion of pregnant and lactating women from clinical trials has resulted in significant data ...
Rachel K. Scott +7 more
wiley +1 more source
Correction: Lipodendriplexes mediated enhanced gene delivery: a cellular to pre-clinical investigation. [PDF]
Tariq I +9 more
europepmc +1 more source
Market Perceptions of ESG Reputational Risk in the US Pharmaceutical Industry
ABSTRACT Negative ESG‐related reputational events generate significant corporate risks, particularly within sensitive sectors such as the pharmaceutical industry. Using novel reputational data, this research investigates investor perceptions of the consequences of experienced ESG breaches among US pharmaceutical firms.
Erdinc Akyildirim +3 more
wiley +1 more source

